iiinova — where your digital self keeps evolving

Art Krieg @artkrieg.bsky.social · 16/09/2026

About to begin the third meeting of the nucleic acid immunology society. Delighted to run into my former postdoc, Gunther Hartmann, who has done so much to advance this field!

020

Art Krieg @artkrieg.bsky.social · 25/04/2026

I love starting the weekend with sunrise on top of Mount Washington!

130

Art Krieg @artkrieg.bsky.social · 28/02/2026

TLR7/8 don't "just" detect viral RNA: they also have an antagonist site to prevent activation by self RNA! Understanding and controlling this system is key to immunotherapy for cancer and autoimmunity. Definitely one of the coolest papers I've read in a long while.

020

Art Krieg @artkrieg.bsky.social · 28/02/2026

The implications are profound, and go beyond TLR7/8: TLR9 uses the same basic design to discriminate self/nonself DNA. Together, TLR7/8/9 must be the key system to distinguish between retroviral particles and normal exosomes: evolution HAD to come up with a way to do this.

031

Art Krieg @artkrieg.bsky.social · 28/02/2026

Every now and then I read a paper that opens my eyes to see an aspect of biology in a new way. This paper blew my mind - TLR7/8 have agonist sites to bind viral RNA, and antagonist sites to bind endogenous RNA degrad. products, enabling self/nonself discrimination: www.nature.com/articles/s41...

nature.com

292

Reposted by Art Krieg

Mark Peifer (He, him) @peiferlabunc.bsky.social · 25/01/2026

As a someone with a 33 year NIH-funded lab whose grant is supposed to be reviewed this week, shut NIH down if that is what's needed to end ICE terrorism. Innocent lives are more important 🧪

7771199

Reposted by Art Krieg

Eric Topol @erictopol.bsky.social · 26/01/2026

Point blank. 10-shots. Execution. A US citizen, a VA ICU Nurse. Then lying. Blocking a real investigation.

18722157

Reposted by Art Krieg

Kai Kupferschmidt @kakape.bsky.social · 25/01/2026

The story is not that there are two conflicting versions of what happened. The story is that the federal government is lying about what happened. There is plenty of evidence. Your job, our job, is to sift that evidence and describe what actually happened ffs.

211029236

Art Krieg @artkrieg.bsky.social · 25/01/2026

May we all be Alex. Our government murdered him, lied about it, and are trying to obstruct justice. We the people demand justice.

010

Art Krieg @artkrieg.bsky.social · 07/11/2025

Just got my poster set up at #SITC2025 and walking my first visitor through our data. If you’re here, stop by poster 919 to learn about the unique biology of TLR7/8/9!

140

Art Krieg @artkrieg.bsky.social · 28/10/2025

Delighted that Luke Timmerman invited me on his Long Run podcast to tell Zola's story. It's been a long run for me, from discovering CpG DNA (TLR9) 30 yrs ago, to now discovering RNA/DNA TLR7/8/9 agonists, which may transform cancer immunotherapy! timmermanreport.com/2025/10/inna...

timmermanreport.com

Innate Immune System Activators for Cancer: Art Krieg on The Long Run - TimmermanReport.com

Art Krieg is today’s guest on The Long Run. Art is the founder and CEO of a Cambridge, Mass.-based startup called Zola Therapeutics. Zola is developing an oligonucleotide drug candidate to activate a ...

040

Reposted by Art Krieg

Florian Ullrich @fullrich.bsky.social · 17/09/2025

Join us for the 3rd Nature Conference on Nucleic Acid Medicines in Boston (Dec 8-10) with an amazing lineup of speakers. 4 weeks left 4 early bird registration! natureconferences.streamgo.live/cracking-the... @natureportfolio.nature.com @nature.com @natbiotech.nature.com @natrevdrugdiscov.nature.com

Nature Conferences. Cracking the Code: Nucleic Acid Medicines Coming of Age. December 8 - 10, Boston, MA, United States. Organized by Alnylam, Ionis, HSCI, Boston Children’s Hospital, and Nature Portfolio

Speakers include: Anna Pyle (Yale),’Arthur Krieg (Zola Therapeutics), Mano Manoharan (Alnylam), Grace Chen (Yale), Howard Chang (Stanford), Maria Barna (Stanford) - picture shows their portraits.

0126

Art Krieg @artkrieg.bsky.social · 19/09/2025

My new review article covers key points I have not seen in any other review of cancer immunotherapy: i) the difference between IFN-a and IFN-b; ii) the unique role of P1 pDC among all DC subsets; iii) the unique role of TLR7/8/9 among TLRs nam10.safelinks.protection.outlook.com?url=http%3A%...

nam10.safelinks.protection.outlook.com

New insights into the role of IFN-α/β and TLR7/8/9 in cancer immunotherapy and systemic autoimmunity

The role of type I interferon (IFN) in mediating tumor immunosurveillance, in situ vaccination, and response to other cancer immunotherapies is well established. The biologic and species-specific diff...

131

Art Krieg @artkrieg.bsky.social · 07/07/2025

I recently had the pleasure of joining The Pharmaverse podcast - it released today. We discussed the parallels between running marathons (and ultras) and my >30 yrs of efforts activating immunity to fight cancer, culminating in founding Zola Rx, starting a biotech is harder! youtu.be/FX9MLqv9PBQ

youtu.be

Season 2, Episode 13: Finding A Path Forward with Art Krieg

YouTube video by The Pharmaverse Podcast

140

Art Krieg @artkrieg.bsky.social · 04/06/2025

Like most immunologists, I tend to use a lot of jargon when talking about cancer immunotherapy - so complex! A patient in one of our prior clinical trials asked me to explain our new approach with TLR7/8/9 agonists, and I made this video on the history, which he liked. youtu.be/KLgCU5Gm3pA

youtu.be

A brief history of cancer immunotherapy, for non-immunologists and patients

YouTube video by Art Krieg

050

Art Krieg @artkrieg.bsky.social · 24/04/2025

Congratulations to you and the whole team for another successful event!

020

Art Krieg @artkrieg.bsky.social · 23/04/2025

Thank you Brad Loncar for hosting us on Biotech TV - Jim and I appreciated the chance to explain how a deeper understanding of type one IFNs can propel cancer immunotherapy forward to greater success! RNA/DNA hybrids costimulate TLR7/8/9, inducing a novel IFN-a response without inflammation!

240

Art Krieg @artkrieg.bsky.social · 14/02/2025

Can Cambridge biotech evolve with the times? I’m an optimist, but the challenges we face are clear and growing…

140

Reposted by Art Krieg

Luke Timmerman @luketimmerman.bsky.social · 11/02/2025

Tickets are SOLD OUT for the TR10 East Coast anniversary party Mar. 6 in Cambridge, Mass. Tickets still available for TR10 West Coast party Mar. 13. Register here. www.eventbrite.com/e/tr10-west-...

eventbrite.com

TR10 West Coast Party

TR10 West Coast Party. Join a stellar cast of biotech leaders at the TR10 West Coast Party for toasts and roasts of founder Luke Timmerman.

031

Art Krieg @artkrieg.bsky.social · 27/01/2025

He might have been getting hypothermic, the windchill was -40 when he finally accepted my “offer”!

110

Art Krieg @artkrieg.bsky.social · 26/01/2025

Cold day going up Mount Washington today with Doug Fambrough, Dave Melville, Jim Ellis, and friends! On the way up, Doug agreed to join me on the board of my new company, Zola therapeutics, getting work done while having fun!

2150

Art Krieg @artkrieg.bsky.social · 03/01/2025

A drug comprising 8 defined live bacterial strains reduces C diff. by >80%, cool!

050

Reposted by Art Krieg

Ardem Patapoutian @ardemp.bskyverified.social · 09/12/2024

I joined 75+ @nobelprize.bsky.social laureates urging US Senators to oppose RFK Jr.'s confirmation as DHHS Secretary. If you’re in a state with GOP senators, PLEASE reach out to them! I’d deeply appreciate it if you amplified this post! 🙏 www.nytimes.com/2024/12/09/h...

14505239

Art Krieg @artkrieg.bsky.social · 01/12/2024

Mount Lafayette and Franconia Ridge are completely different in the winter, my favorite time of year to be up here!#AnotherGreatDayInTheMountains

2110

Art Krieg @artkrieg.bsky.social · 01/12/2024

It’s another great day to be in the mountains! Heading up the Old Bridle Path in Franconia notch…

070

Art Krieg @artkrieg.bsky.social · 30/11/2024

It’s full on winter on Mount Washington, but the Lake of the Clouds hut still provides a nice wind break for hot coffee and a snack. Excellent conditions snowshoeing up ammo. Just past the hut, the trail disappears under deep drifts and there’s no visibility with blowing snow. Back down ammo!

040

Art Krieg @artkrieg.bsky.social · 26/11/2024

In startups I’m always optimistic, thinking we are going to create enormous value in a couple of years. To reduce dilution, I don’t want to raise more cash than I think I’m going to need to get to a big value inflection point. But I’ve learnt you always need more cash than you expect!

020

Art Krieg @artkrieg.bsky.social · 23/11/2024

There’s still time before winter, but it’s nice in the snow too!

010

Art Krieg @artkrieg.bsky.social · 23/11/2024

Sunset right now in the blue Hills, the rocks are still a bit wet from the recent rain, so I’m taking it easy, enjoying the views!

170

Art Krieg @artkrieg.bsky.social · 23/11/2024

For my inaugural post, I’m sharing this recent talk on the immune considerations in mRNA therapeutics. Optimizing CD8+ T cell responses requires understanding the biology of IFN-a/b, which has been ignored in recent cancer immunotherapy review articles. youtu.be/Isz5FqRpqbM

youtu.be

mRNA Therapeutics: immunological issues (from 9th Int. Vaccines R&D Conference, Boston, Nov. 2024)

YouTube video by Art Krieg

0113